Luminex Licenses Components for Genomic Analysis System | GenomeWeb

NEW YORK, April 2 – Luminex of Austin, Texas, said Monday it had licensed two components of Tm Bioscience’s microarray technology for use in its LabMAP, bead-based genomic analysis system.

Toronto-based Tm has also signed a multi-year partnership with Luminex, granting Tm rights to develop and market diagnostic products based on Luminex's LabMAP technology. LabMap uses microspheres, small lasers, digital processors, and software to perform up to 100 assays per drop of fluid.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."